| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB:NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has received approval from the Listing Qualifications Department of Nasdaq to transfer its listing to the Nasdaq Capital Market. The Company's securities will be uplisted to Nasdaq at the opening of business on Tuesday, April 8, 2025. Prior to listing on Nasdaq, the Company's shares traded on the OTCQB. Shareholders are not required to take any action as a result of the uplisting.
The Company's shares will now trade under the ticker symbol "SLSN". The approval by Nasdaq was based on the Company meeting all applicable requirements for public listing on the Nasdaq Capital Market.
"We are pleased to announce our uplisting to Nasdaq," said Jess Jankowski, President and Chief Executive Officer of Solésence. "Solésence continues to redefine mineral-based sun protection as beauty brands recognize the novel skin health benefits from our award-winning products. We believe that trading on Nasdaq will increase our visibility within the investment community, broaden our shareholder base, and deliver greater value to our stakeholders. We look forward to this exciting new chapter in our company's history."
"This milestone was achieved through our team's relentless efforts to profitably achieve our mission, our brand partners' collaboration in driving growth at a multiple of the industry's growth rate, and the patience and resilience of our shareholders. We're particularly excited about how Solésence's uplisting to Nasdaq may one day provide resources to enable our company to scale and increase profitability in a manner not available to most of our competitors," said Kevin Cureton, Chief Operating Officer.
